In recent days, the news that Fosun Pharma and Sancell Group have successively invested in foreign precision medical industry companies has attracted people's attention.
On January 9, Sanpower Group announced the acquisition of a 100% stake in Dendreon, the world's first biopharmaceutical company, Provenge. The acquisition of 819 million US dollars also set a record for the largest amount of pharmaceutical purchases by Chinese companies in the United States.
Coincidentally, Fosun Pharma also announced on the evening of January 10 that the investment of not more than 80 million US dollars and the US Nasdaq-listed company Kite Pharma jointly established a Chinese-foreign contractual joint venture, Fosun Pharma Kate Biotechnology (China) Co., Ltd. Open up the Chinese cancer T cell immunotherapy market.
The two domestic companies have entered the field of “cell immunotherapy†in the form of acquisition and joint venture, respectively, and opened the way for their development of “tumor precision medical market†at home and abroad.
Xinfengkou: Domestic 200 billion precision medical cakes to be divided
At the end of last year, in the “13th Five-Year National Strategic Emerging Industry Development Plan†issued by the State Council, the biomedical industry has become a key industry to encourage development.
The plan proposes that by 2020, the scale of the bio-industry will reach 8 trillion to 10 trillion yuan. In the field of medicine, the rapid development of genetic technology is an opportunity to promote the development of medical care to precision medicine and personalized medicine. It is clearly pointed out that it is necessary to develop new antibodies and vaccines, gene therapy, cell therapy and other biological products and preparations, and develop tumor immunotherapy technology.
In addition to policy support, in terms of funding, the state will invest 60 billion yuan in precision medicine by 2030.
The medical industry revolution brought about by precision medicine has also received much attention. Chen Runsheng, an academician of the Chinese Academy of Sciences, told the media that precision medicine will transform the existing medical system, which is based on medical treatment, hospitals and doctors, into a health protection model that focuses on health protection, health assessment and health intervention for all.
"With the fundamental changes brought by precision medicine to the medical system, it is likely to lead to the transformation and upgrading of a new industry." Chen Runsheng pointed out.
With the change in the way of diagnosis and treatment brought about by precision medicine, it will give birth to huge new medical industry opportunities. With the support of policies and funds, some researchers said that by 2018, the market size of precision medical care in the country will reach 200 billion yuan.
Behind the huge market prospects is huge market demand.
In recent years, chronic diseases such as malignant tumors and cardiovascular and cerebrovascular diseases have occupied the top of the disease death rate of Chinese residents. According to statistics from authoritative departments, the average medical cost for people with malignant tumors is 150,000 yuan. In the case that the traditional medical method has a low cure rate for malignant tumors and a huge cost, the application of precision medicine in the treatment of major diseases such as malignant tumors will have a huge market demand in China.
The main disease mortality and cause of death in Chinese urban residents
A disposable specimen recovery bag is a single-use bag designed to collect and transport biological or medical specimens from one location to another. These bags are typically made of durable, leak-proof materials and feature a secure closure mechanism to prevent spills or contamination. Disposable specimen recovery bags are commonly used in hospitals, clinics, and laboratories to transport samples of blood, urine, tissue, or other bodily fluids for diagnostic testing or research purposes. Once the bag is used, it is disposed of in accordance with biohazard waste regulations to prevent the spread of infectious diseases.
1. Hygienic: Disposable specimen return bags are a very hygienic option because they are used once and then discarded. This helps prevent the spread of infection and cross-contamination.
2. Convenience: These bags are very convenient to use because they can be easily disposed of after use. This eliminates the need for cleaning and disinfection, which can be time-consuming and expensive.
3. Safe: Disposable specimen return bags are a safe choice as they are made of tear and puncture resistant material. This helps prevent accidental release of hazardous substances.
Disposable Endo Retrieval Bag,Disposable Automatic Return Bag,Medical Automatic Recycling Bags,Surgical Medical Detachable Endoscopic Bag
Changzhou Weipu Medical Devices Co., Ltd. , https://www.cnweipumedical.com